ArticlePharmaceuticals (Basel, Switzerland)2022

MK2 Inhibitors as a Potential Crohn's Disease Treatment Approach for Regulating MMP Expression, Cleavage of Checkpoint Molecules and T Cell Activity.

Eric J Lebish et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.